Status:
UNKNOWN
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Oesophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Knowledge of the impact of gene expression profiling could allow optimisation of chemotherapy regimens for individual patients. It could ensure that patients do not receive a particular form of chemot...
Eligibility Criteria
Inclusion
- Any patient with histologically proven operable ,locally advanced and metastatic oesophageal or gastric carcinoma.
Exclusion
- Second malignancy
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00220077
Start Date
June 1 2002
Last Update
November 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden Hospital
Sutton, Surrey, United Kingdom, SM2 5PT